2007-2012
INSERM U850 PIST
Influence of the ugt2b7 promoter region and exon 2 polymorphisms and comedications on acyl-mpag production in vitro and in adult renal transplant patients, Djebli, N.; Picard, N.; Rérolle, J.-P.; Le Meur, Y.; Marquet, P., Pharmacogenetics and Genomics 2007, 17, 321-330, http://doi.org/10.1097/FPC.0b013e32801430f8
Non-invasive imaging correlates with histological and molecular characteristics of an osteosarcoma model: Application for early detection and follow-up of mdr phenotype, Dutour, A.; Leclers, D.; Monteil, J.; Paraf, F.; Charissoux, J. L.; Rousseau, R.; Rigaud, M., Anticancer Research 2007, 27, 4171-4178,
Concomitant intensive chemoradiotherapy induction in non-metastatic inflammatory breast cancer: Long-term follow-up, Genet, D.; Lejeune, C.; Bonnier, P.; Aubard, Y.; Venat-Bouvet, L.; Adjadj, D. J.; Martin, J.; Labourey, J. L., et al., British Journal of Cancer 2007, 97, 883-887, http://doi.org/10.1038/sj.bjc.6603987
Theoretical investigation of the formation of a new series of antioxidant depsides from the radiolysis of flavonoid compounds, Kozlowski, D.; Marsal, P.; Steel, M.; Mokrini, R.; Duroux, J.-L.; Lazzaroni, R.; Trouillas, P., Radiation Research 2007, 168, 243-252, http://doi.org/10.1667/RR0824.1
Density functional theory study of the conformational, electronic, and antioxidant properties of natural chalcones, Kozlowski, D.; Trouillas, P.; Calliste, C.; Marsal, P.; Lazzaroni, R.; Duroux, J.-L., The Journal of Physical Chemistry. A 2007, 111, 1138-1145, http://doi.org/10.1021/jp066496+
Potentially inappropriate medications in the elderly: A french consensus panel list, Laroche, M.-L.; Charmes, J.-P.; Merle, L., European Journal of Clinical Pharmacology 2007, 63, 725-731, http://doi.org/10.1007/s00228-007-0324-2
Is inappropriate medication use a major cause of adverse drug reactions in the elderly?, Laroche, M.-L.; Charmes, J.-P.; Nouaille, Y.; Picard, N.; Merle, L., British Journal of Clinical Pharmacology 2007, 63, 177-186, http://doi.org/10.1111/j.1365-2125.2006.02831.x
Cerebral ischemia probably related to isotretinoin, Laroche, M.-L.; Macian-Montoro, F.; Merle, L.; Vallat, J.-M., The Annals of Pharmacotherapy 2007, 41, 1073-1076, http://doi.org/10.1345/aph.1K028
Individualized mycophenolate mofetil dosing based on drug exposure significantly improves patient outcomes after renal transplantation, Le Meur, Y.; Büchler, M.; Thierry, A.; Caillard, S.; Villemain, F.; Lavaud, S.; Etienne, I.; Westeel, P.-F., et al., American Journal of Transplantation: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2007, 7, 2496-2503, http://doi.org/10.1111/j.1600-6143.2007.01983.x
[pharmacogenetics and immunosuppressor drugs: Impact and clinical interest in transplantation], Marquet, P.; Djebli, N.; Picard, N., Annales Pharmaceutiques Francaises 2007, 65, 382-389,
Metabolism of sirolimus in the presence or absence of cyclosporine by genotyped human liver microsomes and recombinant cytochromes p450 3a4 and 3a5, Picard, N.; Djebli, N.; Sauvage, F.-L.; Marquet, P., Drug Metabolism and Disposition: The Biological Fate of Chemicals 2007, 35, 350-355, http://doi.org/10.1124/dmd.106.012161
Q-switched yb-doped nonlinear microstructured fiber laser for the emission of broadband spectrum, Roy, A.; Laroche, M.; Roy, P.; Leproux, P.; Auguste, J.-L., Optics Letters 2007, 32, 3299-3301, http://doi.org/10.1364/ol.32.003299
Current role of lc-ms in therapeutic drug monitoring, Saint-Marcoux, F.; Sauvage, F.-L.; Marquet, P., Analytical and Bioanalytical Chemistry 2007, 388, 1327-1349, http://doi.org/10.1007/s00216-007-1320-1
Irinotecan-based chemotherapy in a metastatic colorectal cancer patient under haemodialysis for chronic renal dysfunction: Two cases considered, Vénat-Bouvet, L.; Saint-Marcoux, F.; Lagarde, C.; Peyronnet, P.; Lebrun-Ly, V.; Tubiana-Mathieu, N., Anti-Cancer Drugs 2007, 18, 977-980, http://doi.org/10.1097/CAD.0b013e32811d69cb
Microcalorimetric study of the inhibition of butyrylcholinesterase by carbamates, Debord, J.; Laubarie, C.; Dantoine, T., Analytical Biochemistry 2008, 373, 247-252, http://doi.org/10.1016/j.ab.2007.09.023
Protective effect of candesartan in experimental ischemic stroke in the rat mediated by at2 and at4 receptors, Faure, S.; Bureau, A.; Oudart, N.; Javellaud, J.; Fournier, A.; Achard, J.-M., Journal of Hypertension 2008, 26, 2008-2015, http://doi.org/10.1097/HJH.0b013e32830dd5ee
Identification of acepromazine in hair: An illustration of the difficulties encountered in investigating drug-facilitated crimes, Gaulier, J.-M.; Sauvage, F.-L.; Pauthier, H.; Saint-Marcoux, F.; Marquet, P.; Lachâtre, G., Journal of Forensic Sciences 2008, 53, 755-759, http://doi.org/10.1111/j.1556-4029.2008.00706.x
[uterine transplantation: Animal and human studies], Gauthier, T.; Hardeman, S.; Piver, P.; Aubard, Y., Gynecologie, Obstetrique & Fertilite 2008, 36, 1218-1223, http://doi.org/10.1016/j.gyobfe.2008.09.011
[evaluation of accuracy of three assays for human papillomavirus detection and typing: Hybrid capture 2, hpv consensus kit and amplicor hpv], Hantz, S.; Caly, H.; Decroisette, E.; Dutrop, A.; Bakeland, D.; Pascal, B.; Darreye, G.; Dussartre, C., et al., Pathologie-Biologie 2008, 56, 29-35, http://doi.org/10.1016/j.patbio.2007.09.006
An unusual pulmonary complication of cytomegalovirus infection in a renal transplant recipient, Jacques, J.; Dallocchio, A.; Dickson, Z.; Bocquentin, F.; Jebali, H.; Aldigier, J.-C.; Essig, M.; Rerolle, J.-P., NDT plus 2008, 1, 236-238, http://doi.org/10.1093/ndtplus/sfn055
[adrenal metastasis: Survival following surgical resection], Kapella, M.; Genet, D.; Pech De Laclause, B.; Durand-Fontanier, S.; Lachachi, M.; Fabre, A.; Valleix, D.; Descottes, B., Journal De Chirurgie 2008, 145, 346-349,
Ribavirin exposure after the first dose is predictive of sustained virological response in chronic hepatitis c, Loustaud-Ratti, V.; Alain, S.; Rousseau, A.; Hubert, I. F.; Sauvage, F. L.; Marquet, P.; Denis, F.; Lunel, F., et al., Hepatology (Baltimore, Md.) 2008, 47, 1453-1461, http://doi.org/10.1002/hep.22217
[pharmacokinetics and therapeutic drug monitoring of anticancer agents], Marquet, P.; Rousseau, A., Bulletin Du Cancer 2008, 95, 903-909, http://doi.org/10.1684/bdc.2008.0725
[imaging of female infertility], Maubon, A.; Pouquet, M.; Piver, P.; Mazet, N.; Viala-Trentini, M.; Rouanet, J. P., Journal De Radiologie 2008, 89, 172-183,
[splenic trauma: An unusual complication of colonoscopy with polypectomy], Pichon, N.; Mathonnet, M.; Verdière, F.; Carrier, P., Gastroenterologie Clinique Et Biologique 2008, 32, 123-127, http://doi.org/10.1016/j.gcb.2007.10.005
[post therapeutic female pelvis mr imaging], Pouquet, M.; Mathonnet, M.; Aubard, Y.; Rouanet, J.; Maubon, A., Journal De Radiologie 2008, 89, 142-161,
Pitfalls and prevention strategies for liquid chromatography-tandem mass spectrometry in the selected reaction-monitoring mode for drug analysis, Sauvage, F.-L.; Gaulier, J.-M.; Lachâtre, G.; Marquet, P., Clinical Chemistry 2008, 54, 1519-1527, http://doi.org/10.1373/clinchem.2008.105478
Mechanism of the antioxidant action of silybin and 2,3-dehydrosilybin flavonolignans: A joint experimental and theoretical study, Trouillas, P.; Marsal, P.; Svobodová, A.; Vostálová, J.; Gazák, R.; Hrbác, J.; Sedmera, P.; Kren, V., et al., The Journal of Physical Chemistry. A 2008, 112, 1054-1063, http://doi.org/10.1021/jp075814h
Free radical scavenging properties of guaiacol oligomers: A combined experimental and quantum study of the guaiacyl-moiety role, Anouar, E.; Calliste, C. A.; Kosinová, P.; Di Meo, F.; Duroux, J. L.; Champavier, Y.; Marakchi, K.; Trouillas, P., The Journal of Physical Chemistry. A 2009, 113, 13881-13891, http://doi.org/10.1021/jp906285b
New aspects of the antioxidant properties of phenolic acids: A combined theoretical and experimental approach, Anouar, E.; Kosinová, P.; Kozlowski, D.; Mokrini, R.; Duroux, J. L.; Trouillas, P., Physical chemistry chemical physics: PCCP 2009, 11, 7659-7668,
[ovarian tumors], Aubard, Y.; Gauthier, T., La Revue Du Praticien 2009, 59, 1127-1132; quiz 1133,
[should we change our indications for ovarian tissue cryopreservation?], Aubard, Y.; Piver, P.; Gauthier, T., Gynecologie, Obstetrique & Fertilite 2009, 37, 773-774, http://doi.org/10.1016/j.gyobfe.2009.08.002
Tacrolimus population pharmacokinetic-pharmacogenetic analysis and bayesian estimation in renal transplant recipients, Benkali, K.; Prémaud, A.; Picard, N.; Rérolle, J.-P.; Toupance, O.; Hoizey, G.; Turcant, A.; Villemain, F., et al., Clinical Pharmacokinetics 2009, 48, 805-816, http://doi.org/10.2165/11318080-000000000-00000
Microcalorimetric study of the inhibition of butyrylcholinesterase by paraoxon, Debord, J.; Harel, M.; Verneuil, B.; Bollinger, J.-C.; Dantoine, T., Analytical Biochemistry 2009, 389, 97-101, http://doi.org/10.1016/j.ab.2009.03.041
A renal transplant recipient with intraglomerular candida albicans, Dickson, Z.; Bocquentin, F.; Essig, M.; Paraf, F.; Aldigier, J.-C.; Rérolle, J.-P., NDT plus 2009, 2, 329-330, http://doi.org/10.1093/ndtplus/sfp051
[low invasion in sentinel lymph node according to the european working group in breast screening pathology (ewgbsp) recommendations and non sentinel invasion risk in breast cancer], Gauthier, T.; Fermeaux, V.; Mollard, J.; Aubard, Y., Gynecologie, Obstetrique & Fertilite 2009, 37, 481-487, http://doi.org/10.1016/j.gyobfe.2009.04.012
Axillary recurrence after negative sentinel lymph node biopsy under local anesthesia in breast cancer, Gauthier, T.; Mollard, J.; Fermeaux, V.; Kapella, M.; Aubard, Y., European Journal of Surgical Oncology: The Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2009, 35, 464-468, http://doi.org/10.1016/j.ejso.2008.09.008
Effect of mycophenolate acyl-glucuronide on human recombinant type 2 inosine monophosphate dehydrogenase, Gensburger, O.; Picard, N.; Marquet, P., Clinical Chemistry 2009, 55, 986-993, http://doi.org/10.1373/clinchem.2008.113936
[potentially inappropriate medications in the elderly: A list adapted to french medical practice], Laroche, M.-L.; Bouthier, F.; Merle, L.; Charmes, J.-P., La Revue De Medecine Interne 2009, 30, 592-601, http://doi.org/10.1016/j.revmed.2008.08.010
Inappropriate medications in the elderly, Laroche, M. L.; Charmes, J. P.; Bouthier, F.; Merle, L., Clinical Pharmacology and Therapeutics 2009, 85, 94-97, http://doi.org/10.1038/clpt.2008.214
Optimizing ribavirin dosage: A new challenge to improve treatment efficacy in genotype 1 hepatitis c patients, Loustaud-Ratti, V.; Stanke-Labesque, F.; Marquet, P.; Gagnieu, M.-C.; Maynard, M.; Babany, G.; Trépo, C.; OPTIRIB, F. R. G., Gastroenterologie Clinique Et Biologique 2009, 33, 580-583, http://doi.org/10.1016/j.gcb.2009.04.009
Performance of the new mycophenolate assay based on impdh enzymatic activity for pharmacokinetic investigations and setup of bayesian estimators in different populations of allograft recipients, Marquet, P.; Saint-Marcoux, F.; Prémaud, A.; Sauvage, F.-L.; Jaqz-Aigrain, E.; Knoop, C.; Lebranchu, Y.; Tiberi, M., et al., Therapeutic Drug Monitoring 2009, 31, 443-450, http://doi.org/10.1097/FTD.0b013e3181a8f0ae
Pharmacokinetic optimization of immunosuppressive therapy in thoracic transplantation: Part ii, Monchaud, C.; Marquet, P., Clinical Pharmacokinetics 2009, 48, 489-516, http://doi.org/10.2165/11317240-000000000-00000
Pharmacokinetic optimization of immunosuppressive therapy in thoracic transplantation: Part i, Monchaud, C.; Marquet, P., Clinical Pharmacokinetics 2009, 48, 419-462, http://doi.org/10.2165/11317230-000000000-00000
General unknown screening procedure for the characterization of human drug metabolites: Application to loratadine phase i metabolism, Picard, N.; Dridi, D.; Sauvage, F.-L.; Boughattas, N. A.; Marquet, P., Journal of Separation Science 2009, 32, 2209-2217, http://doi.org/10.1002/jssc.200900099
Pharmacokinetic modelling and development of bayesian estimators for therapeutic drug monitoring of mycophenolate mofetil in reduced-intensity haematopoietic stem cell transplantation, Saint-Marcoux, F.; Royer, B.; Debord, J.; Larosa, F.; Legrand, F.; Deconinck, E.; Kantelip, J.-P.; Marquet, P., Clinical Pharmacokinetics 2009, 48, 667-675, http://doi.org/10.2165/11317140-000000000-00000
General unknown screening procedure for the characterization of human drug metabolites in forensic toxicology: Applications and constraints, Sauvage, F.-L.; Picard, N.; Saint-Marcoux, F.; Gaulier, J.-M.; Lachâtre, G.; Marquet, P., Journal of Separation Science 2009, 32, 3074-3083, http://doi.org/10.1002/jssc.200900092
Feasibility of ribavirin therapeutic drug monitoring in hepatitis c, Sauvage, F.-L.; Stanke-Labesque, F.; Gagnieu, M.-C.; Jourdil, J.-F.; Babany, G.; Marquet, P., Therapeutic Drug Monitoring 2009, 31, 374-381, http://doi.org/10.1097/FTD.0b013e3181a665e3
Population pharmacokinetics and bayesian estimation of tacrolimus exposure in renal transplant recipients on a new once-daily formulation, Benkali, K.; Rostaing, L.; Premaud, A.; Woillard, J.-B.; Saint-Marcoux, F.; Urien, S.; Kamar, N.; Marquet, P., et al., Clinical Pharmacokinetics 2010, 49, 683-692, http://doi.org/10.2165/11535950-000000000-00000
[sternal cleft: Repair during the neonatal period], Beurdeley, M.; Gauthier, T.; Bedu, A.; Fourcade, L., Archives De Pediatrie: Organe Officiel De La Societe Francaise De Pediatrie 2010, 17, 1477-1479, http://doi.org/10.1016/j.arcped.2010.07.012
Conservative treatment of big yolk sac tumour of the ovary in young girl, Beurdeley, M.; Gauthier, T.; Piguet, C.; Fourcade, L., Journal of Visceral Surgery 2010, 147, e265-267, http://doi.org/10.1016/j.jviscsurg.2010.08.007
Familial 18 centromere variant resulting in difficulties in interpreting prenatal interphase fish, Bourthoumieu, S.; Esclaire, F.; Terro, F.; Brosset, P.; Fiorenza, M.; Aubard, V.; Beguet, M.; Yardin, C., Morphologie: Bulletin De l’Association Des Anatomistes 2010, 94, 68-72, http://doi.org/10.1016/j.morpho.2010.02.016
Osteonecrosis of the jaw induced by clodronate, an alkylbiphosphonate: Case report and literature review, Crépin, S.; Laroche, M.-L.; Sarry, B.; Merle, L., European Journal of Clinical Pharmacology 2010, 66, 547-554, http://doi.org/10.1007/s00228-010-0822-5
[a child behind an epilepsy: Clinic and therapeutic wavering], Dantoine, F.; Castaing, M. A.; Dumont, C.; Laroche, C.; Thuillier, C., Archives De Pediatrie: Organe Officiel De La Societe Francaise De Pediatrie 2010, 17, 654-655, http://doi.org/10.1016/S0929-693X(10)70045-2
Screening of pesticides in blood with liquid chromatography-linear ion trap mass spectrometry, Dulaurent, S.; Moesch, C.; Marquet, P.; Gaulier, J.-M.; Lachâtre, G., Analytical and Bioanalytical Chemistry 2010, 396, 2235-2249, http://doi.org/10.1007/s00216-009-3443-z
Crystal-storing histiocytosis with renal fanconi syndrome: Pathological and molecular characteristics compared with classical myeloma-associated fanconi syndrome, El Hamel, C.; Thierry, A.; Trouillas, P.; Bridoux, F.; Carrion, C.; Quellard, N.; Goujon, J.-M.; Aldigier, J.-C., et al., Nephrology, Dialysis, Transplantation: Official Publication of the European Dialysis and Transplant Association – European Renal Association 2010, 25, 2982-2990, http://doi.org/10.1093/ndt/gfq129
[why not creating a n4 stage in breast cancer?], Gauthier, T.; Bourneton, N.; Mollard, J.; Aubard, Y., Gynecologie, Obstetrique & Fertilite 2010, 38, 439-441, http://doi.org/10.1016/j.gyobfe.2010.02.002
[how i… Remove axillary sentinel lymph node under local anesthesia], Gauthier, T.; Garuchet-Bigot, A.; Mollard, J.; Aubard, Y., Gynecologie, Obstetrique & Fertilite 2010, 38, 418-419, http://doi.org/10.1016/j.gyobfe.2010.04.004
Contralateral axillary involvement in breast cancer recurrence: Locoregional disease or metastasis?, Gauthier, T.; Monteil, J.; Bourneton, N.; Jammet, I.; Tubiana, N.; Aubard, Y., European Journal of Gynaecological Oncology 2010, 31, 694-696,
[chemotherapy and women fertility preservation], Gauthier, T.; Piver, P.; Durand, L.-M.; Donadel, L.; Pech, J.-C.; Roux, C.; Aubard, Y., Presse Medicale (Paris, France: 1983) 2010, 39, 786-793, http://doi.org/10.1016/j.lpm.2010.01.011
Polymorphisms in type i and ii inosine monophosphate dehydrogenase genes and association with clinical outcome in patients on mycophenolate mofetil, Gensburger, O.; Van Schaik, R. H. N.; Picard, N.; Le Meur, Y.; Rousseau, A.; Woillard, J.-B.; Van Gelder, T.; Marquet, P., Pharmacogenetics and Genomics 2010, 20, 537-543, http://doi.org/10.1097/FPC.0b013e32833d8cf5
Drug-resistant cytomegalovirus in transplant recipients: A french cohort study, Hantz, S.; Garnier-Geoffroy, F.; Mazeron, M.-C.; Garrigue, I.; Merville, P.; Mengelle, C.; Rostaing, L.; Saint Marcoux, F., et al., The Journal of Antimicrobial Chemotherapy 2010, 65, 2628-2640, http://doi.org/10.1093/jac/dkq368
Fertility after embolization of the uterine arteries to treat obstetrical hemorrhage: A review of 53 cases, Hardeman, S.; Decroisette, E.; Marin, B.; Vincelot, A.; Aubard, Y.; Pouquet, M.; Maubon, A., Fertility and Sterility 2010, 94, 2574-2579, http://doi.org/10.1016/j.fertnstert.2010.02.052
Severe sirolimus-induced acute hepatitis in a renal transplant recipient, Jacques, J.; Dickson, Z.; Carrier, P.; Essig, M.; Guillaudeau, A.; Lacour, C.; Bocquentin, F.; Aldigier, J.-C., et al., Transplant International: Official Journal of the European Society for Organ Transplantation 2010, 23, 967-970, http://doi.org/10.1111/j.1432-2277.2010.01100.x
Counterpoint: Is pharmacokinetic or pharmacodynamic monitoring of calcineurin inhibition therapy necessary?, Marquet, P., Clinical Chemistry 2010, 56, 736-739, http://doi.org/10.1373/clinchem.2009.138693
Stability of ribavirin concentrations depending on the type of blood collection tube and preanalytical conditions, Marquet, P.; Sauvage, F.-L.; Loustaud-Ratti, V.; Babany, G.; Rousseau, A.; Lachâtre, G., Therapeutic Drug Monitoring 2010, 32, 237-241, http://doi.org/10.1097/FTD.0b013e3181d3f686
Uterine junctional zone at magnetic resonance imaging: A predictor of in vitro fertilization implantation failure, Maubon, A.; Faury, A.; Kapella, M.; Pouquet, M.; Piver, P., The Journal of Obstetrics and Gynaecology Research 2010, 36, 611-618, http://doi.org/10.1111/j.1447-0756.2010.01189.x
The role of organic anion-transporting polypeptides and their common genetic variants in mycophenolic acid pharmacokinetics, Picard, N.; Yee, S. W.; Woillard, J.-B.; Lebranchu, Y.; Le Meur, Y.; Giacomini, K. M.; Marquet, P., Clinical Pharmacology and Therapeutics 2010, 87, 100-108, http://doi.org/10.1038/clpt.2009.205
Contribution of the different udp-glucuronosyltransferase (ugt) isoforms to buprenorphine and norbuprenorphine metabolism and relationship with the main ugt polymorphisms in a bank of human liver microsomes, Rouguieg, K.; Picard, N.; Sauvage, F.-L.; Gaulier, J.-M.; Marquet, P., Drug Metabolism and Disposition: The Biological Fate of Chemicals 2010, 38, 40-45, http://doi.org/10.1124/dmd.109.029546
Cost-effectiveness analysis of individualized mycophenolate mofetil dosing in kidney transplant patients in the apomygre trial, Rousseau, A.; Laroche, M.-L.; Venisse, N.; Loichot-Roselmac, C.; Turcant, A.; Hoizey, G.; Compagnon, P.; Hary, L., et al., Transplantation 2010, 89, 1255-1262, http://doi.org/10.1097/TP.0b013e3181d75952
Pharmacokinetic modeling and development of bayesian estimators in kidney transplant patients receiving the tacrolimus once-daily formulation, Saint-Marcoux, F.; Debord, J.; Undre, N.; Rousseau, A.; Marquet, P., Therapeutic Drug Monitoring 2010, 32, 129-135, http://doi.org/10.1097/FTD.0b013e3181cc70db
Risk of diarrhoea in a long-term cohort of renal transplant patients given mycophenolate mofetil: The significant role of the ugt1a8 2 variant allele, Woillard, J.-B.; Rerolle, J.-P.; Picard, N.; Rousseau, A.; Drouet, M.; Munteanu, E.; Essig, M.; Marquet, P., et al., British Journal of Clinical Pharmacology 2010, 69, 675-683, http://doi.org/10.1111/j.1365-2125.2010.03625.x
Donor p-gp polymorphisms strongly influence renal function and graft loss in a cohort of renal transplant recipients on cyclosporine therapy in a long-term follow-up, Woillard, J.-B.; Rerolle, J.-P.; Picard, N.; Rousseau, A.; Guillaudeau, A.; Munteanu, E.; Essig, M.; Drouet, M., et al., Clinical Pharmacology and Therapeutics 2010, 88, 95-100, http://doi.org/10.1038/clpt.2010.62
[sentinel node biopsy under local anesthesia in breast cancer: The pros], Aubard, Y.; Gauthier, T.; Mollard, J., Gynecologie, Obstetrique & Fertilite 2011, 39, 259-261, http://doi.org/10.1016/j.gyobfe.2011.02.004
Erythropoietin restores c-fiber function and prevents pressure ulcer formation in diabetic mice, Demiot, C.; Sarrazy, V.; Javellaud, J.; Gourloi, L.; Botelle, L.; Oudart, N.; Achard, J.-M., The Journal of Investigative Dermatology 2011, 131, 2316-2322, http://doi.org/10.1038/jid.2011.211
Are all cases of low-grade mosaic trisomy 13 in amniotic fluid with no fetal malformation in fact confined placental mosaicism? A case report, Etoubleau, C.; Bourthoumieu, S.; Fiorenza, M.; Aubard, V.; Yardin, C., Morphologie: Bulletin De l’Association Des Anatomistes 2011, 95, 142-145, http://doi.org/10.1016/j.morpho.2011.07.117
Radiodermatitis prevention with sucralfate in breast cancer: Fundamental and clinical studies, Falkowski, S.; Trouillas, P.; Duroux, J.-L.; Bonnetblanc, J.-M.; Clavère, P., Supportive Care in Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer 2011, 19, 57-65, http://doi.org/10.1007/s00520-009-0788-y
Uterine allotransplantation in ewes using an aortocava patch, Gauthier, T.; Bertin, F.; Fourcade, L.; Maubon, A.; Saint Marcoux, F.; Piver, P.; Marquet, P.; Pommepuy, I., et al., Human Reproduction (Oxford, England) 2011, 26, 3028-3036, http://doi.org/10.1093/humrep/der288
[conservative management of placenta percreta invading the bladder: Be patient], Gauthier, T.; Garuchet-Bigot, A.; Benacquista, M.; Odin, I.; Decroisette, E.; Vincelot, A.; Nathan-Denizot, N.; Maubon, A., et al., Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction 2011, 40, 169-173, http://doi.org/10.1016/j.jgyn.2010.09.010
[not available], Goirand, F.; Royer, B.; Hulin, A.; Saint-Marcoux, F.; Thérapeutique, p. l. g. S. T. P. d. l. S. F. d. P. e. d., Therapie 2011, 66, 57-61, http://doi.org/10.2515/therapie/2010025
Dimerisation process of silybin-type flavonolignans: Insights from theory, Košinová, P.; Gažák, R.; Duroux, J.-L.; Lazzaroni, R.; Křen, V.; Assfeld, X.; Trouillas, P., Chemphyschem: A European Journal of Chemical Physics and Physical Chemistry 2011, 12, 1135-1142, http://doi.org/10.1002/cphc.201100066
Quantitative proteomic analysis of cyclosporine-induced toxicity in a human kidney cell line and comparison with tacrolimus, Lamoureux, F.; Mestre, E.; Essig, M.; Sauvage, F. L.; Marquet, P.; Gastinel, L. N., Journal of Proteomics 2011, 75, 677-694, http://doi.org/10.1016/j.jprot.2011.09.005
Determination of dodine in fruit samples by liquid chromatography electrospray ionization-tandem mass spectrometry, Le Grand, R.; Saint-Marcoux, F.; Dulaurent, S.; Sauvage, F.-L.; Moesch, C.; Lachâtre, G., Journal of AOAC International 2011, 94, 300-306,
Pharmacological exposure to ribavirin: A key player in the complex network of factors implicated in virological response and anaemia in hepatitis c treatment, Loustaud-Ratti, V.; Carrier, P.; Rousseau, A.; Maynard, M.; Babany, G.; Alain, S.; Trépo, C.; De Ledinghen, V., et al., Digestive and Liver Disease: Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2011, 43, 850-855, http://doi.org/10.1016/j.dld.2011.04.002
Non-invasive detection of hepatic amyloidosis: Fibroscan, a new tool, Loustaud-Ratti, V. R.; Cypierre, A.; Rousseau, A.; Yagoubi, F.; Abraham, J.; Fauchais, A.-L.; Carrier, P.; Lefebvre, A., et al., Amyloid: The International Journal of Experimental and Clinical Investigation: The Official Journal of the International Society of Amyloidosis 2011, 18, 19-24, http://doi.org/10.3109/13506129.2010.543443
Lymph node assessment with (18)f-fdg-pet and mri in uterine cervical cancer, Monteil, J.; Maubon, A.; Leobon, S.; Roux, S.; Marin, B.; Renaudie, J.; Genet, D.; Fermeaux, V., et al., Anticancer Research 2011, 31, 3865-3871,
Interaction of sirolimus and everolimus with hepatic and intestinal organic anion-transporting polypeptide transporters, Picard, N.; Levoir, L.; Lamoureux, F.; Yee, S. W.; Giacomini, K. M.; Marquet, P., Xenobiotica; the Fate of Foreign Compounds in Biological Systems 2011, 41, 752-757, http://doi.org/10.3109/00498254.2011.573882
The influence of pharmacogenetics and cofactors on clinical outcomes in kidney transplantation, Picard, N.; Marquet, P., Expert Opinion on Drug Metabolism & Toxicology 2011, 7, 731-743, http://doi.org/10.1517/17425255.2011.570260
Cyp3a5 genotype does not influence everolimus in vitro metabolism and clinical pharmacokinetics in renal transplant recipients, Picard, N.; Rouguieg-Malki, K.; Kamar, N.; Rostaing, L.; Marquet, P., Transplantation 2011, 91, 652-656, http://doi.org/10.1097/TP.0b013e31820ae4ac
Value of liver stiffness measured by transient elastography in the liver transplant pre-operative evaluation of the potential deceased liver donors: Preliminary study, Pichon, N.; Loustaud-Ratti, V.; Clavel, M.; Carrier, P.; Amiel, J. B.; Labrousse, F., Clinical Transplantation 2011, 25, E205-210, http://doi.org/10.1111/j.1399-0012.2010.01386.x
Inhibition of t-cell activation and proliferation by mycophenolic acid in patients awaiting liver transplantation: Pk/pd relationships, Prémaud, A.; Rousseau, A.; Johnson, G.; Canivet, C.; Gandia, P.; Muscari, F.; Peron, J. M.; Rostaing, L., et al., Pharmacological Research 2011, 63, 432-438, http://doi.org/10.1016/j.phrs.2011.01.005
Population pharmacokinetics of mycophenolic acid in pediatric renal transplant patients using parametric and nonparametric approaches, Prémaud, A.; Weber, L. T.; Tönshoff, B.; Armstrong, V. W.; Oellerich, M.; Urien, S.; Marquet, P.; Rousseau, A., Pharmacological Research 2011, 63, 216-224, http://doi.org/10.1016/j.phrs.2010.10.017
Development and evaluation of a simulation procedure to take into account various assays for the bayesian dose adjustment of tacrolimus, Saint-Marcoux, F.; Debord, J.; Parant, F.; Labalette, M.; Kamar, N.; Rostaing, L.; Rousseau, A.; Marquet, P., Therapeutic Drug Monitoring 2011, 33, 171-177, http://doi.org/10.1097/FTD.0b013e31820d6ef7
Development of a bayesian estimator for the therapeutic drug monitoring of mycophenolate mofetil in children with idiopathic nephrotic syndrome, Saint-Marcoux, F.; Guigonis, V.; Decramer, S.; Gandia, P.; Ranchin, B.; Parant, F.; Bessenay, L.; Libert, F., et al., Pharmacological Research 2011, 63, 423-431, http://doi.org/10.1016/j.phrs.2011.01.009
Large scale analysis of routine dose adjustments of mycophenolate mofetil based on global exposure in renal transplant patients, Saint-Marcoux, F.; Vandierdonck, S.; Prémaud, A.; Debord, J.; Rousseau, A.; Marquet, P., Therapeutic Drug Monitoring 2011, 33, 285-294, http://doi.org/10.1097/FTD.0b013e31821633a6
Post-transplant lymphoproliferative disease (ptld): Pharmacological, virological and other determinants, Stojanova, J.; Caillard, S.; Rousseau, A.; Marquet, P., Pharmacological Research 2011, 63, 1-7, http://doi.org/10.1016/j.phrs.2010.10.016
Population pharmacokinetic model and bayesian estimator for two tacrolimus formulations–twice daily prograf and once daily advagraf, Woillard, J.-B.; de Winter, B. C. M.; Kamar, N.; Marquet, P.; Rostaing, L.; Rousseau, A., British Journal of Clinical Pharmacology 2011, 71, 391-402, http://doi.org/10.1111/j.1365-2125.2010.03837.x
[lead poisoning by fishing sinker ingestion], Carrier, P.; Legros, R.; Le Sidaner, A.; Morel, A.; Harry, P.; Moesch, C.; Sautereau, D.; Ly, K.-H., et al., La Revue De Medecine Interne 2012, 33, 697-699, http://doi.org/10.1016/j.revmed.2012.09.004
Bordetella holmesii bacteremia in a renal transplant recipient: Emergence of a new pathogen, Chambaraud, T.; Dickson, Z.; Ensergueix, G.; Barraud, O.; Essig, M.; Lacour, C.; Allard, J.; Bocquentin, F., et al., Transplant Infectious Disease: An Official Journal of the Transplantation Society 2012, 14, E134-136, http://doi.org/10.1111/tid.12009
[photodynamic therapy for the treatment of extramammary paget’s disease], Clément, E.; Sparsa, A.; Doffoel-Hantz, V.; Durox, H.; Prey, S.; Bonnetblanc, J.-M.; Caly, H.; Aubard, Y., et al., Annales De Dermatologie Et De Venereologie 2012, 139, 103-108, http://doi.org/10.1016/j.annder.2011.10.414
Bayesian estimation of mycophenolate mofetil in lung transplantation, using a population pharmacokinetic model developed in kidney and lung transplant recipients, de Winter, B. C. M.; Monchaud, C.; Prémaud, A.; Pison, C.; Kessler, R.; Reynaud-Gaubert, M.; Dromer, C.; Stern, M., et al., Clinical Pharmacokinetics 2012, 51, 29-39, http://doi.org/10.2165/11594050-000000000-00000
Voriconazole stability in cement spacers, Denes, E.; Fiorenza, F.; Saint-Marcoux, F.; Megherbi, M.; Dupon, M.; Weinbreck, P., Medecine Et Maladies Infectieuses 2012, 42, 567-568, http://doi.org/10.1016/j.medmal.2012.07.007
Calcineurin regulation of cytoskeleton organization: A new paradigm to analyse the effects of calcineurin inhibitors on the kidney, Descazeaud, V.; Mestre, E.; Marquet, P.; Essig, M., Journal of Cellular and Molecular Medicine 2012, 16, 218-227, http://doi.org/10.1111/j.1582-4934.2011.01398.x
Highlights on anthocyanin pigmentation and copigmentation: A matter of flavonoid π-stacking complexation to be described by dft-d, Di Meo, F.; Sancho Garcia, J. C.; Dangles, O.; Trouillas, P., Journal of Chemical Theory and Computation 2012, 8, 2034-2043, http://doi.org/10.1021/ct300276p
Simultaneous evaluation of six human glucuronidation activities in liver microsomes using liquid chromatography-tandem mass spectrometry, Gagez, A.-L.; Rouguieg-Malki, K.; Sauvage, F.-L.; Marquet, P.; Picard, N., Analytical Biochemistry 2012, 427, 52-59, http://doi.org/10.1016/j.ab.2012.04.031
Lanreotide autogel 90 mg and lymphorrhea prevention after axillary node dissection in breast cancer: A phase iii double blind, randomized, placebo-controlled trial, Gauthier, T.; Garuchet-Bigot, A.; Marin, B.; Mollard, J.; Loum, O.; Fermeaux, V.; Jammet, I.; Kanoun, D., et al., European Journal of Surgical Oncology: The Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2012, 38, 902-909, http://doi.org/10.1016/j.ejso.2012.05.009
[the age of the patient over 70 is a contraindication to perform para-aortic lymphadenectomy for ovarian cancer], Gauthier, T.; Gouy, S.; Uzan, C.; Kane, A.; Morice, P., Gynecologie, Obstetrique & Fertilite 2012, 40, 330-332, http://doi.org/10.1016/j.gyobfe.2012.02.017
Obesity and cervical ripening failure risk, Gauthier, T.; Mazeau, S.; Dalmay, F.; Eyraud, J.-L.; Catalan, C.; Marin, B.; Aubard, Y., The Journal of Maternal-Fetal & Neonatal Medicine: The Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians 2012, 25, 304-307, http://doi.org/10.3109/14767058.2011.575485
[uterus transplantation. Current situation], Gauthier, T.; Piver, P.; Mesnard, C.; Marquet, P.; Pichon, N.; Guillaudeau, A.; Drouet, M.; Gardet, E., et al., Gynecologie, Obstetrique & Fertilite 2012, 40, 691-694, http://doi.org/10.1016/j.gyobfe.2012.09.011
Positioning of antioxidant quercetin and its metabolites in lipid bilayer membranes: Implication for their lipid-peroxidation inhibition, Košinová, P.; Berka, K.; Wykes, M.; Otyepka, M.; Trouillas, P., The Journal of Physical Chemistry. B 2012, 116, 1309-1318, http://doi.org/10.1021/jp208731g
Mapping cyclosporine-induced changes in protein secretion by renal cells using stable isotope labeling with amino acids in cell culture (silac), Lamoureux, F.; Gastinel, L. N.; Mestre, E.; Marquet, P.; Essig, M., Journal of Proteomics 2012, 75, 3674-3687, http://doi.org/10.1016/j.jprot.2012.04.024
Sirolimus and everolimus intestinal absorption and interaction with calcineurin inhibitors: A differential effect between cyclosporine and tacrolimus, Lamoureux, F.; Picard, N.; Boussera, B.; Sauvage, F.-L.; Marquet, P., Fundamental & Clinical Pharmacology 2012, 26, 463-472, http://doi.org/10.1111/j.1472-8206.2011.00957.x
Simultaneous determination of five synthetic pyrethroid metabolites in urine by liquid chromatography-tandem mass spectrometry: Application to 39 persons without known exposure to pyrethroids, Le Grand, R.; Dulaurent, S.; Gaulier, J. M.; Saint-Marcoux, F.; Moesch, C.; Lachâtre, G., Toxicology Letters 2012, 210, 248-253, http://doi.org/10.1016/j.toxlet.2011.08.016
Lc-ms vs. Gc-ms, online extraction systems, advantages of technology for drug screening assays, Marquet, P., Methods in Molecular Biology (Clifton, N.J.) 2012, 902, 15-27, http://doi.org/10.1007/978-1-61779-934-1_2
Population pharmacokinetic modelling and design of a bayesian estimator for therapeutic drug monitoring of tacrolimus in lung transplantation, Monchaud, C.; de Winter, B. C.; Knoop, C.; Estenne, M.; Reynaud-Gaubert, M.; Pison, C.; Stern, M.; Kessler, R., et al., Clinical Pharmacokinetics 2012, 51, 175-186, http://doi.org/10.2165/11594760-000000000-00000
Untargeted screening of urinary peptides with liquid chromatography coupled to hybrid linear-ion trap tandem mass spectrometry, Sauvage, F.-L.; Gastinel, L. N.; Marquet, P., Journal of Chromatography. A 2012, 1259, 138-147, http://doi.org/10.1016/j.chroma.2012.04.006
Lc-ms/ms screen for xenobiotics and metabolites, Sauvage, F.-L.; Marquet, P., Methods in Molecular Biology (Clifton, N.J.) 2012, 902, 129-138, http://doi.org/10.1007/978-1-61779-934-1_11
